X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-01 | EW | Edwards Lifesciences Corp | Mussallem Michael A | Dir | S - Sale+OE | $84.46 | -29,350 | 4,074,822 | -1% | -$2,478,839 | |||||
2023-05-30 | ALGN | Align Technology Inc | Dallas Kevin J | Dir | P - Purchase | $285.26 | +7,000 | 12,246 | +133% | +$1,996,800 | ||||||
2023-05-24 | RBOT | Vicarious Surgical Inc. | Morris June | CLO, GC, Secretary | S - Sale | $2.31 | -2,500 | 299,307 | -1% | -$5,768 | ||||||
| D | 2023-05-24 | EW | Edwards Lifesciences Corp | Wood Larry L | Global Pres TAVR, Surg | S - Sale+OE | $84.23 | -6,421 | 214,290 | -3% | -$540,841 | |||||
2023-05-22 | RWLK | Rewalk Robotics Ltd. | Jasinski Lawrence J | CEO | S - Sale | $0.61 | -11,457 | 604,433 | -2% | -$6,980 | ||||||
2023-05-22 | RBOT | Vicarious Surgical Inc. | Morris June | CLO, GC, Secretary | S - Sale | $2.25 | -6,408 | 301,807 | -2% | -$14,397 | ||||||
2023-05-22 | RBOT | Vicarious Surgical Inc. | Khalifa Sammy | CTO, 10% | S - Sale | $2.25 | -19,401 | 949,827 | -2% | -$43,695 | ||||||
2023-05-22 | RBOT | Vicarious Surgical Inc. | Kelly William John | CFO, Treasurer | S - Sale | $2.26 | -6,479 | 274,759 | -2% | -$14,612 | ||||||
2023-05-22 | RBOT | Vicarious Surgical Inc. | Sachs Adam David | Pres, CEO, 10% | S - Sale | $2.24 | -24,252 | 1,178,395 | -2% | -$54,366 | ||||||
2023-05-16 | STE | Steris Plc | Breeden Richard C | Dir | S - Sale | $208.61 | -12,130 | 55,212 | -18% | -$2,530,439 | ||||||
| D | 2023-05-16 | STE | Steris Plc | Feldmann Cynthia L | Dir | S - Sale+OE | $209.06 | -2,058 | 9,368 | -18% | -$430,239 | |||||
2023-05-17 | EAR | Eargo, Inc. | Gormsen Christian | Pres, CEO | S - Sale | $4.69 | -58 | 6,065 | -1% | -$272 | ||||||
2023-05-17 | EAR | Eargo, Inc. | Brownie William | COO | S - Sale | $4.69 | -14 | 8,293 | 0% | -$66 | ||||||
2023-05-17 | EAR | Eargo, Inc. | Laponis Adam | CFO | S - Sale | $4.69 | -19 | 3,171 | -1% | -$89 | ||||||
2023-05-17 | EAR | Eargo, Inc. | Thorpe Mark | Chief Accounting Officer | S - Sale | $4.69 | -3 | 1,067 | 0% | -$14 | ||||||
2023-05-15 | CDRE | Cadre Holdings, Inc. | Sokolow Nicolas | Dir | S - Sale | $21.34 | -12,000 | 1,042,899 | -1% | -$256,055 | ||||||
2023-05-12 | UEEC | United Health Products, Inc. | Thom Brian David | CEO | S - Sale | $0.19 | -300,000 | 1,054,671 | -22% | -$57,000 | ||||||
| D | 2023-05-15 | STE | Steris Plc | Sohi Mohsen | Dir | S - Sale+OE | $212.28 | -2,069 | 22,361 | -8% | -$439,207 | |||||
| D | 2023-05-15 | STE | Steris Plc | Kosecoff Jacqueline B | Dir | S - Sale+OE | $212.56 | -4,657 | 26,639 | -15% | -$989,892 | |||||
2023-05-15 | STE | Steris Plc | Breeden Richard C | Dir | S - Sale | $211.00 | -2,737 | 67,342 | -4% | -$577,507 | ||||||
2023-05-10 | RBOT | Vicarious Surgical Inc. | Liang Philip | Dir | P - Purchase | $1.99 | +7,000 | 2,257,240 | 0% | +$13,958 | ||||||
| D | 2023-05-10 | EW | Edwards Lifesciences Corp | Bobo Donald E Jr | CVP,Strategy, Corp Development | S - Sale+OE | $89.22 | -2,500 | 206,674 | -1% | -$223,050 | |||||
| D | 2023-05-10 | EW | Edwards Lifesciences Corp | Ullem Scott B. | CVP, CFO | S - Sale+OE | $88.54 | -80,700 | 276,116 | -23% | -$7,145,004 | |||||
| D | 2023-05-10 | EW | Edwards Lifesciences Corp | Mussallem Michael A | COB, CEO | S - Sale+OE | $88.49 | -19,875 | 4,070,337 | 0% | -$1,758,653 | |||||
| D | 2023-05-08 | ENOV | Enovis Corp | Vinnakota Rajiv | Dir | S - Sale+OE | $57.18 | -1,396 | 11,901 | -10% | -$79,823 | |||||
| D | 2023-05-09 | EW | Edwards Lifesciences Corp | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | S - Sale+OE | $88.68 | -6,640 | 172,090 | -4% | -$588,835 | |||||
| D | 2023-05-09 | EW | Edwards Lifesciences Corp | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $88.94 | -75,600 | 28,531 | -73% | -$6,724,234 | |||||
| D | 2023-05-05 | EW | Edwards Lifesciences Corp | Bobo Donald E Jr | CVP,Strategy, Corp Development | S - Sale+OE | $88.63 | -5,635 | 206,674 | -3% | -$499,402 | |||||
2023-05-05 | RBOT | Vicarious Surgical Inc. | Kelly William John | CFO, Treasurer | S - Sale | $2.16 | -5,039 | 281,238 | -2% | -$10,889 | ||||||
| D | 2023-05-01 | ISRG | Intuitive Surgical Inc | Barratt Craig H | Dir | S - Sale+OE | $306.00 | -2,000 | 25,351 | -7% | -$612,000 | |||||
| D | 2023-04-28 | ISRG | Intuitive Surgical Inc | Rubash Mark J | Dir | S - Sale+OE | $300.00 | -7,323 | 15,482 | -32% | -$2,196,900 | |||||
| D | 2023-04-28 | EW | Edwards Lifesciences Corp | Sellers Robert W.A. | SVP, Corporate Controller | S - Sale+OE | $87.20 | -12,270 | 32,159 | -28% | -$1,069,944 | |||||
| DM | 2023-04-21 | ISRG | Intuitive Surgical Inc | Rosa David J. | EVP Chief Strategy, Growth Of | S - Sale+OE | $298.56 | -81,564 | 155,712 | -34% | -$24,351,619 | |||||
| D | 2023-04-21 | ISRG | Intuitive Surgical Inc | Rubash Mark J | Dir | S - Sale+OE | $297.92 | -1,683 | 15,000 | -10% | -$501,401 | |||||
2023-04-21 | ISRG | Intuitive Surgical Inc | Rubash Mark J | Dir | S - Sale | $297.93 | -8,135 | 15,000 | -35% | -$2,423,689 | ||||||
2023-04-21 | ISRG | Intuitive Surgical Inc | Widman Fredrik | VP Corporate Controller | S - Sale | $297.87 | -630 | 2,233 | -22% | -$187,658 | ||||||
| D | 2023-04-21 | ISRG | Intuitive Surgical Inc | Desantis Robert | EVP, Chief Product Officer | S - Sale+OE | $297.92 | -8,623 | 7,065 | -55% | -$2,568,981 | |||||
| D | 2023-04-21 | ISRG | Intuitive Surgical Inc | Barratt Craig H | Dir | S - Sale+OE | $297.92 | -6,000 | 24,696 | -20% | -$1,787,524 | |||||
| D | 2023-04-21 | ISRG | Intuitive Surgical Inc | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $299.76 | -9,623 | 327 | -97% | -$2,884,579 | |||||
| D | 2023-04-14 | EW | Edwards Lifesciences Corp | Mussallem Michael A | COB, CEO | S - Sale+OE | $84.20 | -19,875 | 4,040,060 | 0% | -$1,673,434 | |||||
2023-04-11 | RBOT | Vicarious Surgical Inc. | Liang Philip | Dir | P - Purchase | $2.26 | +17,002 | 2,250,240 | +1% | +$38,408 | ||||||
2023-04-10 | RBOT | Vicarious Surgical Inc. | Liang Philip | Dir | P - Purchase | $2.20 | +5,925 | 1,532,833 | 0% | +$13,035 | ||||||
2023-04-06 | RBOT | Vicarious Surgical Inc. | Liang Philip | Dir | P - Purchase | $2.05 | +3,000 | 2,227,313 | 0% | +$6,150 | ||||||
2023-04-05 | RBOT | Vicarious Surgical Inc. | Kelly William John | CFO, Treasurer | S - Sale | $2.15 | -4,911 | 286,277 | -2% | -$10,567 | ||||||
| D | 2023-04-06 | EW | Edwards Lifesciences Corp | Bobo Donald E Jr | CVP,Strategy, Corp Development | S - Sale+OE | $83.09 | -6,725 | 218,588 | -3% | -$558,801 | |||||
| D | 2023-04-06 | EW | Edwards Lifesciences Corp | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | S - Sale+OE | $83.10 | -6,640 | 169,138 | -4% | -$551,766 | |||||
2023-04-03 | ENOV | Enovis Corp | Shirley Brady | Pres, COO | S - Sale | $53.54 | -695 | 61,291 | -1% | -$37,210 | ||||||
2023-03-28 | RBOT | Vicarious Surgical Inc. | Liang Philip | Dir | P - Purchase | $2.32 | +74,300 | 2,224,313 | +3% | +$172,227 | ||||||
2023-03-27 | RBOT | Vicarious Surgical Inc. | Liang Philip | Dir | P - Purchase | $2.07 | +73,900 | 2,150,013 | +4% | +$152,973 | ||||||
2023-03-24 | RBOT | Vicarious Surgical Inc. | Liang Philip | Dir | P - Purchase | $1.65 | +60,125 | 2,076,113 | +3% | +$99,146 | ||||||
2023-03-23 | RBOT | Vicarious Surgical Inc. | Liang Philip | Dir | P - Purchase | $1.71 | +73,500 | 2,015,988 | +4% | +$125,538 | ||||||
| M | 2023-03-22 | RBOT | Vicarious Surgical Inc. | Morris June | CLO, GC, Secretary | S - Sale | $1.89 | -3,218 | 308,215 | -1% | -$6,070 | |||||
2023-03-22 | RBOT | Vicarious Surgical Inc. | Khalifa Sammy | CTO, 10% | S - Sale | $2.38 | -3,220 | 969,228 | 0% | -$7,667 | ||||||
2023-03-22 | RBOT | Vicarious Surgical Inc. | Kelly William John | CFO, Treasurer | S - Sale | $2.39 | -1,139 | 291,188 | 0% | -$2,720 | ||||||
2023-03-22 | RBOT | Vicarious Surgical Inc. | Sachs Adam David | Pres, CEO, 10% | S - Sale | $2.45 | -4,263 | 1,202,647 | 0% | -$10,449 | ||||||
2023-03-20 | ENOV | Enovis Corp | Berry Phillip Benjamin (Ben) | SVP, CFO | S - Sale | $51.84 | -600 | 20,868 | -3% | -$31,104 | ||||||
| D | 2023-03-17 | ZBH | Zimmer Biomet Holdings, Inc. | Phipps Chad F | SVP, GC, Secretary | S - Sale+OE | $124.50 | -23,045 | 43,671 | -35% | -$2,869,113 | |||||
| D | 2023-03-16 | ENOV | Enovis Corp | Perfall A Clayton | Dir | S - Sale+OE | $52.13 | -2,793 | 34,515 | -7% | -$145,585 | |||||
2023-03-15 | ESTA | Establishment Labs Holdings Inc. | Gillin Leslie | Dir | S - Sale | $67.62 | -3,759 | 3,599 | -51% | -$254,184 | ||||||
2023-03-15 | RWLK | Rewalk Robotics Ltd. | Jasinski Lawrence J | CEO | P - Purchase | $0.72 | +15,000 | 616,086 | +2% | +$10,811 | ||||||
| D | 2023-03-15 | EW | Edwards Lifesciences Corp | Chopra Daveen | CVP, TMTT | S - Sale+OE | $77.47 | -4,435 | 18,911 | -19% | -$343,563 | |||||
| D | 2023-03-14 | EW | Edwards Lifesciences Corp | Mussallem Michael A | COB, CEO | S - Sale+OE | $77.61 | -19,875 | 4,030,560 | 0% | -$1,542,513 | |||||
| M | 2023-03-10 | RBOT | Vicarious Surgical Inc. | Liang Philip | Dir | P - Purchase | $2.36 | +59,100 | 1,942,488 | +3% | +$139,366 | |||||
2023-03-09 | RBOT | Vicarious Surgical Inc. | Liang Philip | Dir | P - Purchase | $2.50 | +37,100 | 1,883,388 | +2% | +$92,624 | ||||||
2023-03-06 | ENOV | Enovis Corp | Pryor Daniel A | EVP, Strategy, Business Dev. | S - Sale | $57.69 | -1,898 | 110,222 | -2% | -$109,496 | ||||||
2023-03-06 | ENOV | Enovis Corp | Trerotola Matthew L. | Pres, CEO | S - Sale | $57.69 | -6,743 | 197,388 | -3% | -$389,004 | ||||||
2023-03-06 | ENOV | Enovis Corp | Lang Patricia A | SVP, CHRO | S - Sale | $57.69 | -745 | 19,653 | -4% | -$42,979 | ||||||
2023-03-06 | ENOV | Enovis Corp | Tandy Bradley J | SVP, GC | S - Sale | $57.69 | -1,092 | 16,019 | -6% | -$62,997 | ||||||
2023-03-06 | ENOV | Enovis Corp | Shirley Brady | Pres, COO | S - Sale | $57.69 | -2,102 | 61,986 | -3% | -$121,264 | ||||||
| D | 2023-03-08 | EW | Edwards Lifesciences Corp | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | S - Sale+OE | $76.96 | -6,640 | 168,875 | -4% | -$510,996 | |||||
| D | 2023-03-08 | EW | Edwards Lifesciences Corp | Bobo Donald E Jr | CVP,Strategy, Corp Development | S - Sale+OE | $76.96 | -6,725 | 218,195 | -3% | -$517,558 | |||||
| M | 2023-03-06 | RWLK | Rewalk Robotics Ltd. | Lind Global Fund II LP | 10% | P - Purchase | $0.80 | +237,233 | 5,031,200 | +5% | +$188,765 | |||||
2023-03-06 | RBOT | Vicarious Surgical Inc. | Kelly William John | CFO, Treasurer | S - Sale | $2.68 | -4,954 | 292,327 | -2% | -$13,277 | ||||||
2023-03-03 | STE | Steris Plc | Majors Cary L | SVP, Pres, Healthcare | S - Sale | $190.21 | -1,150 | 11,345 | -9% | -$218,742 | ||||||
2023-03-02 | RBOT | Vicarious Surgical Inc. | Liang Philip | Dir | P - Purchase | $2.60 | +30,000 | 1,846,288 | +2% | +$77,952 | ||||||
2023-03-01 | MSA | Msa Safety Inc | Roberts Rebecca B | Dir | S - Sale | $134.28 | -1,949 | 9,331 | -17% | -$261,718 | ||||||
| D | 2023-02-27 | ENOV | Enovis Corp | Pryor Daniel A | EVP, Strategy, Business Dev. | S - Sale+OE | $56.08 | -5,716 | 112,120 | -5% | -$320,553 | |||||
| D | 2023-02-27 | ENOV | Enovis Corp | Tandy Bradley J | SVP, GC | S - Sale+OE | $56.08 | -2,491 | 17,111 | -13% | -$139,695 | |||||
| D | 2023-02-27 | ENOV | Enovis Corp | Shirley Brady | Pres, COO | S - Sale+OE | $56.07 | -8,156 | 64,088 | -11% | -$457,307 | |||||
| D | 2023-02-27 | ENOV | Enovis Corp | Trerotola Matthew L. | Pres, CEO | S - Sale+OE | $56.21 | -18,917 | 204,131 | -8% | -$1,063,325 | |||||
| D | 2023-02-27 | ENOV | Enovis Corp | Lang Patricia A | SVP, CHRO | S - Sale+OE | $56.09 | -1,963 | 20,398 | -9% | -$110,105 | |||||
| D | 2023-03-01 | ISRG | Intuitive Surgical Inc | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $228.47 | -1,253 | 1,950 | -39% | -$286,273 | |||||
2023-02-27 | MSA | Msa Safety Inc | Buck Jonathan D. | Chief Accounting Officer | S - Sale | $135.29 | -713 | 3,361 | -18% | -$96,462 | ||||||
2023-02-24 | RBOT | Vicarious Surgical Inc. | Morris June | CLO, GC, Secretary | S - Sale | $2.81 | -2,500 | 311,433 | -1% | -$7,023 | ||||||
2023-02-23 | RBOT | Vicarious Surgical Inc. | Liang Philip | Dir | P - Purchase | $2.86 | +37,500 | 1,816,288 | +2% | +$107,141 | ||||||
2023-02-22 | RBOT | Vicarious Surgical Inc. | Liang Philip | Dir | P - Purchase | $2.83 | +12,500 | 1,778,788 | +1% | +$35,433 | ||||||
| M | 2023-02-21 | ENOV | Enovis Corp | Shirley Brady | Pres, COO | S - Sale | $58.72 | -2,722 | 46,733 | -6% | -$159,848 | |||||
| M | 2023-02-21 | ENOV | Enovis Corp | Lang Patricia A | SVP, CHRO | S - Sale | $58.76 | -985 | 14,416 | -6% | -$57,878 | |||||
| M | 2023-02-21 | ENOV | Enovis Corp | Trerotola Matthew L. | Pres, CEO | S - Sale | $58.29 | -7,725 | 162,544 | -5% | -$450,252 | |||||
| M | 2023-02-21 | ENOV | Enovis Corp | Berry Phillip Benjamin (Ben) | SVP, CFO | S - Sale | $59.73 | -539 | 16,630 | -3% | -$32,197 | |||||
| M | 2023-02-21 | ENOV | Enovis Corp | Pryor Daniel A | EVP, Strategy, Business Dev. | S - Sale | $58.35 | -2,219 | 75,443 | -3% | -$129,475 | |||||
| M | 2023-02-21 | ENOV | Enovis Corp | Tandy Bradley J | SVP, GC | S - Sale | $58.42 | -1,224 | 12,621 | -9% | -$71,507 | |||||
2023-02-21 | ENOV | Enovis Corp | Kleckner John | Principal Accounting Officer | S - Sale | $61.45 | -134 | 2,342 | -5% | -$8,234 | ||||||
2023-02-21 | RBOT | Vicarious Surgical Inc. | Khalifa Sammy | CTO, 10% | S - Sale | $2.82 | -18,830 | 972,448 | -2% | -$53,148 | ||||||
2023-02-21 | RBOT | Vicarious Surgical Inc. | Morris June | CLO, GC, Secretary | S - Sale | $2.79 | -6,218 | 313,933 | -2% | -$17,318 | ||||||
2023-02-21 | RBOT | Vicarious Surgical Inc. | Kelly William John | CFO, Treasurer | S - Sale | $2.79 | -6,287 | 297,281 | -2% | -$17,519 | ||||||
2023-02-21 | RBOT | Vicarious Surgical Inc. | Sachs Adam David | Pres, CEO, 10% | S - Sale | $2.78 | -23,538 | 1,206,910 | -2% | -$65,382 | ||||||
2023-02-17 | EAR | Eargo, Inc. | Laponis Adam | CFO | S - Sale | $7.37 | -21 | 3,190 | -1% | -$155 | ||||||
2023-02-17 | EAR | Eargo, Inc. | Thorpe Mark | Chief Accounting Officer | S - Sale | $7.42 | -4 | 1,070 | 0% | -$30 | ||||||
2023-02-17 | EAR | Eargo, Inc. | Brownie William | COO | S - Sale | $7.37 | -15 | 8,307 | 0% | -$111 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |